Wnts in adult brain: From synaptic plasticity to cognitive deficiencies

Frontiers in Cellular Neuroscience

Volumn 7, Issue DEC, 2013, Pages

  Oliva, Carolina A ^a   Vargas, Jessica Y ^a   Inestrosa, Nibaldo C ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Activity dependent processes; Neurodegenerative diseases; Spontaneous activity; Wnt in adult brain; Wnt in circuit development; Wnt signaling pathways

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ACTIVATING TRANSCRIPTION FACTOR 2; AMYLOID BETA PROTEIN; AXIN; BETA CATENIN; BONE MORPHOGENETIC PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CALCINEURIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM ION; CASEIN KINASE IALPHA; CYCLIC GMP; CYCLIN D1; DIACYLGLYCEROL; DICKKOPF 1 PROTEIN; FRIZZLED PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; INOSITOL 1, 4, 5 TRISPHOSPHATE; LYMPHOID ENHANCER FACTOR 1; PHOSPHOLIPASE C; POSTSYNAPTIC DENSITY PROTEIN 95; PRESENILIN 1; PROTEIN KINASE C; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; UNINDEXED DRUG; WNT PROTEIN; WNT3A PROTEIN; WNT5A PROTEIN; WNT7A PROTEIN; WNT7B PROTEIN;

ALZHEIMER DISEASE; ARTICLE; BASOLATERAL AMYGDALA; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; COGNITIVE DEFECT; CONNECTOME; DEGENERATIVE DISEASE; DISEASE COURSE; EPILEPSY; HUMAN; IN SITU HYBRIDIZATION; MEMORY CONSOLIDATION; MENTAL DISEASE; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; PROTEIN EXPRESSION; SEIZURE; SYNAPTOGENESIS; WNT SIGNALING PATHWAY;

EID: 84889684938     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2013.00224     Document Type: Article

References (228)

1. Aberle, H., Bauer, A., Stappert, J., Kispert, A., and Kemler, R. (1997). Beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 16, 3797-3804. doi: 10.1093/emboj/16.13.3797
2. Adler, P. N. (2002). Planar signaling and morphogenesis in Drosophila. Dev. Cell 2, 525-535. doi: 10.1016/S1534-5807(02)00176-4
3. Ahmad-Annuar, A., Ciani, L., Simeonidis, I., Herreros, J., Fredj, N. B., Rosso, S. B., et al. (2006). Signaling across the synapse: a role for Wnt and dishevelled in presynaptic assembly and neurotransmitter release. J. Cell Biol. 174, 127-139. doi: 10.1083/jcb.200511054
4. Ahnaou, A., and Drinkenburg, W. H. (2011). Disruption of glycogen synthase kinase-3-beta activity leads to abnormalities in physiological measures in mice. Behav. Brain Res. 221, 246-252. doi: 10.1016/j.bbr.2011.03.004
5. Alimohamad, H., Rajakumar, N., Seah, Y. H., and Rushlow, W. (2005a). Antipsychotics alter the protein expression levels of beta-catenin and GSK-3 in the rat medial prefrontal cortex and striatum. Biol. Psychiatry 57, 533-542. doi: 10.1016/j.biopsych.2004.11.036
6. Alimohamad, H., Sutton, L., Mouyal, J., Rajakumar, N., and Rushlow, W. J. (2005b). The effects of antipsychotics on beta-catenin, glycogen synthase kinase-3 and dishevelled in the ventral midbrain of rats. J. Neurochem. 95, 513-525. doi: 10.1111/j.1471-4159.2005.03388.x
7. Alvarez, A. R., Godoy, J. A., Mullendorff, K., Olivares, G. H., Bronfman, M., and Inestrosa, N. C. (2004). Wnt-3a overcomes beta-amyloid toxicity in rat hippocampal neurons. Exp. Cell Res. 297, 186-196. doi: 10.1016/j.yexcr.2004. 02.028
8. Alvarez, G., Munoz-Montano, J. R., Satrustegui, J., Avila, J., Bogonez, E., and Diaz-Nido, J. (1999). Lithium protects cultured neurons against beta-amyloid-induced neurodegeneration. FEBS Lett. 453, 260-264. doi: 10.1016/S0014-5793(99)00685-7
9. Alvarez, V. A., and Sabatini, B. L. (2007). Anatomical and physiological plasticity of dendritic spines. Annu. Rev. Neurosci. 30, 79-97. doi:10.1146/annurev.neuro.30.051606.094222
10. Arrazola, M. S., Varela-Nallar, L., Colombres, M., Toledo, E. M., Cruzat, F., Pavez, L., et al. (2009). Calcium/calmodulin-dependent protein kinase type IV is a target gene of the Wnt/beta-catenin signaling pathway. J. Cell. Physiol. 221, 658-667. doi:10.1002/jcp.21902
11. Avila, M. E., Sepulveda, F. J., Burgos, C. F., Moraga-Cid, G., Parodi, J., Moon, R. T., et al. (2010). Canonical Wnt3a modulates intracellular calcium and enhances excitatory neurotransmission in hippocampal neurons. J. Biol. Chem. 285, 18939-18947. doi: 10.1074/jbc.M110.103028
12. Barclay, J., Balaguero, N., Mione, M., Ackerman, S. L., Letts, V. A., Brodbeck, J., et al. (2001). Ducky mouse phenotype of epilepsy and ataxia is associated with mutations in the Cacna2d2 gene and decreased calcium channel current in cerebellar Purkinje cells. J. Neurosci. 21, 6095-6104.
13. Beaulieu, J. M., Gainetdinov, R. R., and Caron, M. G. (2009). Akt/GSK3 signaling in the action of psychotropic drugs. Annu. Rev. Pharmacol. Toxicol. 49, 327-347. doi: 10.1146/annurev.pharmtox.011008.145634
14. Beaulieu, J. M., Sotnikova, T. D., Marion, S., Lefkowitz, R. J., Gainetdinov, R. R., and Caron, M. G. (2005). An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 122, 261-273. doi: 10.1016/j.cell.2005.05.012
15. Beaulieu, J. M., Sotnikova, T. D., Yao, W. D., Kockeritz, L., Woodgett, J. R., Gainetdinov, R. R., et al. (2004). Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc. Natl. Acad. Sci. U.S.A. 101, 5099-5104. doi: 10.1073/pnas.0307921101
16. Beaulieu, J. M., Zhang, X., Rodriguiz, R. M., Sotnikova, T. D., Cools, M. J., Wetsel, W. C., et al. (2008). Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency. Proc. Natl. Acad. Sci. U.S.A. 105, 1333-1338. doi: 10.1073/pnas.0711496105
17. Ben-Ari, Y., Cherubini, E., Corradetti, R., and Gaiarsa, J. L. (1989). Giant synaptic potentials in immature rat CA3 hippocampal neurones. J. Physiol. 416, 303-325
18. Berwick, D. C., and Harvey, K. (2012). The importance of Wnt signalling for neurodegeneration in Parkinson's disease. Biochem. Soc. Trans. 40, 1123-1128. doi: 10.1042/BST20120122
19. Beurel, E., Song, L., and Jope, R. S. (2011). Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice. Mol. Psychiatry 16, 1068-1070. doi: 10.1038/mp.2011.47
20. Bhanot, P., Brink, M., Samos, C. H., Hsieh, J. C., Wang, Y., Macke, J. P., et al. (1996). A new member of the frizzled family from Drosophila functions as a Wingless receptor. Nature 382, 225-230. doi: 10.1038/382225a0
21. Bilic, J., Huang, Y. L., Davidson, G., Zimmermann, T., Cruciat, C. M., Bienz, M., et al. (2007). Wnt induces LRP6 signalosomes and promotes disheveled dependent LRP6 phosphorylation. Science 316, 1619-1622. doi: 10.1126/science. 1137065
22. Blalock, E. M., Geddes, J. W., Chen, K. C., Porter, N. M., Markesbery, W. R., and Landfield, P. W. (2004). Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc. Natl. Acad. Sci. U.S.A. 101, 2173-2178. doi: 10.1073/pnas.0308512100
23. Bosch, M., and Hayashi, Y. (2012). Structural plasticity of dendritic spines. Curr. Opin. Neurobiol. 22, 383-388. doi: 10.1016/j.conb.2011.09.002
24. Boutros, M., Paricio, N., Strutt, D. I., and Mlodzik, M. (1998). Dishevelled activates JNK and discriminates between JNK pathways in planar polarity and wingless signaling. Cell 94, 109-118. doi: 10.1016/S0092-8674(00)81226-X
25. Budnik, V., and Salinas, P. C. (2011). Wnt signaling during synaptic development and plasticity. Curr. Opin. Neurobiol. 21, 151-159. doi: 10.1016/j.conb.2010.12.002
26. Busceti, C. L., Biagioni, F., Aronica, E., Riozzi, B., Storto, M., Battaglia, G., et al. (2007). Induction of the Wnt inhibitor, Dickkopf-1, is associated with neurodegeneration related to temporal lobe epilepsy. Epilepsia 48, 694-705. doi: 10.1111/j.1528-1167.2007.01055.x
27. Busciglio, J., Lorenzo, A., Yeh, J., and Yankner, B. A. (1995). beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 14, 879-888. doi: 10.1016/0896-6273(95)90232-5
28. Cadigan, K. M., and Liu, Y. I. (2006). Wnt signaling: complexity at the surface. J. Cell Sci. 119, 395-402. doi: 10.1242/jcs.02826
29. Cadigan, K. M., and Nusse, R. (1997). Wnt signaling: a common theme in animal development. Genes Dev. 11, 3286-3305. doi: 10.1101/gad.11.24.3286
30. Cappuccio, I., Calderone, A., Busceti, C. L., Biagioni, F., Pontarelli, F., Bruno, V., et al. (2005). Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is required for the development of ischemic neuronal death. J. Neurosci. 25, 2647-2657. doi: 10.1523/JNEUROSCI.5230-04.2005
31. Caricasole, A., Copani, A., Caraci, F., Aronica, E., Rozemuller, A. J., Caruso, A., et al. (2004). Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain. J. Neurosci. 24, 6021-6027. doi: 10.1523/JNEUROSCI.1381-04.2004
32. Cerpa, W., Farias, G. G., Godoy, J. A., Fuenzalida, M., Bonansco, C., and Inestrosa, N. C. (2010). Wnt-5a occludes Abeta oligomer-induced depression of glutamatergic transmission in hippocampal neurons. Mol. Neurodegener. 5, 3. doi: 10.1186/1750-1326-5-3
33. Cerpa, W., Gambrill, A., Inestrosa, N. C., and Barria, A. (2011). Regulation of NMDA-receptor synaptic transmission by Wnt signaling. J. Neurosci. 31, 9466-9471. doi: 10.1523/JNEUROSCI.6311-10.2011
34. Cerpa, W., Godoy, J. A., Alfaro, I., Farias, G. G., Metcalfe, M. J., Fuentealba, R., et al. (2008). Wnt-7a modulates the synaptic vesicle cycle and synaptic transmission in hippocampal neurons. J. Biol. Chem. 283, 5918-5927. doi:10.1074/jbc.M705943200
35. Chacon, M. A., Varela-Nallar, L., and Inestrosa, N. C. (2008). Frizzled-1 is involved in the neuroprotective effect of Wnt3a against Abeta oligomers. J. Cell. Physiol. 217, 215-227. doi: 10.1002/jcp.21497
36. Chattopadhyaya, B., and Cristo, G. D. (2012). GABAergic circuit dysfunctions in neurodevelopmental disorders. Front. Psychiatry 3:51. doi:10.3389/fpsyt.2012.00051
37. Chen, J., Park, C. S., and Tang, S. J. (2006). Activity-dependent synaptic Wnt release regulates hippocampal long term potentiation. J. Biol. Chem. 281, 11910-11916. doi: 10.1074/jbc.M511920200
38. Chen, G., Rajkowska, G., Du, F., Seraji-Bozorgzad, N., and Manji, H. K. (2000). Enhancement of hippocampal neurogenesis by lithium. J. Neurochem. 75, 1729-1734. doi: 10.1046/j.1471-4159.2000.0751729.x
39. Ciani, L., Boyle, K. A., Dickins, E., Sahores, M., Anane, D., Lopes, D. M., et al. (2011). Wnt7a signaling promotes dendritic spine growth and synaptic strength through Ca(2)(+)/Calmodulin-dependent protein kinase II. Proc. Natl. Acad. Sci. U.S.A. 108, 10732-10737. doi: 10.1073/pnas.1018132108
40. Clevers, H., and Nusse, R. (2012). Wnt/beta-catenin signaling and disease. Cell 149, 1192-1205. doi: 10.1016/j.cell.2012.05.012
41. Cliffe, A., Hamada, F., and Bienz, M. (2003). A role of dishevelled in relocating Axin to the plasma membrane during wingless signaling. Curr. Biol. 13, 960-966. doi:10.1016/S0960-9822(03)00370-1
42. Contestabile, A., Greco, B., Ghezzi, D., Tucci, V., Benfenati, F., and Gasparini, L. (2013). Lithium rescues synaptic plasticity and memory in Down syndrome mice. J. Clin. Invest. 123, 348-361. doi: 10.1172/JCI64650
43. Cruciat, C. M., and Niehrs, C. (2013). Secreted and transmembrane Wnt inhibitors and activators. Cold Spring Harb. Perspect. Med. 3, a015081. doi: 10.1101/cshperspect.a015081
44. Cuitino, L., Godoy, J. A., Farias, G. G., Couve, A., Bonansco, C., Fuenzalida, M., et al. (2010). Wnt-5a modulates recycling of functional GABAA receptors on hippocampal neurons. J. Neurosci. 30, 8411-8420. doi: 10.1523/JNEUROSCI.5736-09.2010
45. Davis, E. K., Zou, Y., and Ghosh, A. (2008). Wnts acting through canonical and noncanonical signaling pathways exert opposite effects on hippocampal synapse formation. Neural Dev. 3, 32. doi: 10.1186/1749-8104-3-32
46. De Ferrari, G. V., Chacon, M. A., Barria, M. I., Garrido, J. L., Godoy, J. A., Olivares, G., et al. (2003). Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils. Mol. Psychiatry 8, 195-208. doi: 10.1038/sj.mp.4001208
47. De Ferrari, G. V., and Moon, R. T. (2006). The ups and downs of Wnt signaling in prevalent neurological disorders. Oncogene 25, 7545-7553. doi:10.1038/sj.onc.1210064
48. De Ferrari, G. V., Papassotiropoulos, A., Biechele, T., Wavrant De-Vrieze, F., Avila, M. E., Major, M. B., et al. (2007). Common genetic variation within the low-density lipoprotein receptor-related protein 6 and late-onset Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 104, 9434-9439. doi: 10.1073/pnas.0603523104
49. DeMattos, R. B., Cirrito, J. R., Parsadanian, M., May, P. C., O'Dell, M. A., Taylor, J. W., et al. (2004). ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo. Neuron 41, 193-202. doi: 10.1016/S0896-6273(03)00850-X
50. Duman, R. S., and Monteggia, L. M. (2006). A neurotrophic model for stress-related mood disorders. Biol. Psychiatry 59, 1116-1127. doi:10.1016/j.biopsych.2006.02.013
51. Duman, R. S., and Voleti, B. (2012). Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents. Trends Neurosci. 35, 47-56. doi: 10.1016/j.tins.2011.11.004
52. Egorov, A. V., and Draguhn, A. (2012). Development of coherent neuronal activity patterns in mammalian cortical networks: common principles and local hetereogeneity. Mech. Dev. 130, 412-423. doi: 10.1016/j.mod.2012.09.006
53. Engel, T., Goni-Oliver, P., Lucas, J. J., Avila, J., and Hernandez, F. (2006a). Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert. J. Neurochem. 99, 1445-1455. doi: 10.1111/j.1471-4159.2006.04139.x
54. Engel, T., Hernandez, F., Avila, J., and Lucas, J. J. (2006b). Full reversal of Alzheimer's disease-like phenotype in a mouse model with conditional overexpression of glycogen synthase kinase-3. J. Neurosci. 26, 5083-5090. doi:10.1523/JNEUROSCI.0604-06.2006
55. Ernst, W. L., Zhang, Y., Yoo, J. W., Ernst, S. J., and Noebels, J. L. (2009). Genetic enhancement of thalamocortical network activity by elevating alpha 1g-mediated low-voltage-activated calcium current induces pure absence epilepsy. J. Neurosci. 29, 1615-1625. doi: 10.1523/JNEUROSCI.2081-08.2009
56. Errington, A. C., Stohr, T., and Lees, G. (2005). Voltage gated ion channels: targets for anticonvulsant drugs. Curr. Top. Med. Chem. 5, 15-30. doi:10.2174/1568026053386872
57. Farias, G. G., Alfaro, I. E., Cerpa, W., Grabowski, C. P., Godoy, J. A., Bonansco, C., et al. (2009). Wnt-5a/JNK signaling promotes the clustering of PSD-95 in hippocampal neurons. J. Biol. Chem. 284, 15857-15866. doi:10.1074/jbc.M808986200
58. Farias, G. G., Valles, A. S., Colombres, M., Godoy, J. A., Toledo, E. M., Lukas, R. J., et al. (2007). Wnt-7a induces presynaptic colocalization of alpha 7-nicotinic acetylcholine receptors and adenomatous polyposis coli in hippocampal neurons. J. Neurosci. 27, 5313-5325. doi: 10.1523/JNEUROSCI.3934-06.2007
59. Feller, M. B., Wellis, D. P., Stellwagen, D., Werblin, F. S., and Shatz, C. J. (1996). Requirement for cholinergic synaptic transmission in the propagation of spontaneous retinal waves. Science 272, 1182-1187. doi: 10.1126/science.272. 5265.1182
60. Fernandez, F., Morishita, W., Zuniga, E., Nguyen, J., Blank, M., Malenka, R. C., et al. (2007). Pharmacotherapy for cognitive impairment in a mouse model of down syndrome. Nat. Neurosci. 10, 411-413. doi:10.1038/nn1860
61. Finch, P. W., He, X., Kelley, M. J., Uren, A., Schaudies, R. P., Popescu, N. C., et al. (1997). Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action. Proc. Natl. Acad. Sci. U.S.A. 94, 6770-6775. doi:10.1073/pnas.94.13.6770
62. Fortress, A. M., Schram, S. L., Tuscher, J. J., and Frick, K. M. (2013). Canonical Wnt signaling is necessary for object recognition memory consolidation. J. Neurosci. 33, 12619-12626. doi: 10.1523/JNEUROSCI.0659-13.2013
63. Foster, T. C., and McNaughton, B. L. (1991). Long-term enhancement of CA1 synaptic transmission is due to increased quantal size, not quantal content. Hippocampus 1, 79-91. doi: 10.1002/hipo.450010108
64. Fradkin, L. G., Dura, J. M., and Noordermeer, J. N. (2010). Ryks: new partners for Wnts in the developing and regenerating nervous system. Trends Neurosci. 33, 84-92. doi: 10.1016/j.tins.2009.11.005
65. Fragoso, M. A., Yi, H., Nakamura, R. E., and Hackam, A. S. (2011). The Wnt signaling pathway protects retinal ganglion cell 5 (RGC-5) cells from elevated pressure. Cell Mol. Neurobiol. 31, 163-173. doi: 10.1007/s10571-010-9603-z
66. Ftouh, S., Akbar, M. T., Hirsch, S. R., and de Belleroche, J. S. (2005). Downregulation of Dickkopf 3, a regulator of the Wnt signalling pathway, in elderly schizophrenic subjects. J. Neurochem. 94, 520-530. doi: 10.1111/j.1471-4159.2005.03239.x
67. Galvan, V., Gorostiza, O. F., Banwait, S., Ataie, M., Logvinova, A. V., Sitaraman, S., et al. (2006). Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664. Proc. Natl. Acad. Sci. U.S.A. 103, 7130-7135. doi: 10.1073/pnas.0509695103
68. Gao, C., and Chen, Y. G. (2010). Dishevelled: the hub of Wnt signaling. Cell. Signal. 22, 717-727. doi: 10.1016/j.cellsig.2009.11.021
69. Garaschuk, O., Hanse, E., and Konnerth, A. (1998). Developmental profile and synaptic origin of early network oscillations in the CA1 region of rat neonatal hippocampus. J. Physiol. 507(Pt 1), 219-236. doi: 10.1111/j.1469-7793.1998.219bu.x
70. Garrido, J. L., Godoy, J. A., Alvarez, A., Bronfman, M., and Inestrosa, N. C. (2002). Protein kinase C inhibits amyloid beta peptide neurotoxicity by acting on members of the Wnt pathway. FASEB J. 16, 1982-1984. doi:10.1096/fj.02-0327fje
71. Gogolla, N., Galimberti, I., Deguchi, Y., and Caroni, P. (2009). Wnt signaling mediates experience-related regulation of synapse numbers and mossy fiber connectivities in the adult hippocampus. Neuron 62, 510-525. doi:10.1016/j.neuron.2009.04.022
72. Golbs, A., Nimmervoll, B., Sun, J. J., Sava, I. E., and Luhmann, H. J. (2011). Control of programmed cell death by distinct electrical activity patterns. Cereb. Cortex 21, 1192-1202. doi: 10.1093/cercor/bhq200
73. Gordon, M. D., and Nusse, R. (2006). Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J. Biol. Chem. 281, 22429-22433. doi: 10.1074/jbc.R600015200
74. Gould, T. D., Chen, G., and Manji, H. K. (2004). In vivo evidence in the brain for lithium inhibition of glycogen synthase kinase-3. Neuropsychopharmacology 29, 32-38. doi: 10.1038/sj.npp.1300283
75. Gould, T. D., Einat, H., O'Donnell, K. C., Picchini, A. M., Schloesser, R. J., and Manji, H. K. (2007). Beta-catenin overexpression in the mouse brain phenocopies lithium-sensitive behaviors. Neuropsychopharmacology 32, 2173-2183. doi: 10.1038/sj.npp.1301338
76. Gould, T. D., and Manji, H. K. (2002). The Wnt signaling pathway in bipolar disorder. Neuroscientist 8, 497-511. doi: 10.1177/107385802237176
77. Green, J. L., Kuntz, S. G., and Sternberg, P. W. (2008). Ror receptor tyrosine kinases: orphans no more. Trends Cell Biol. 18, 536-544. doi: 10.1016/j.tcb.2008.08.006
78. Grimes, C. A., and Jope, R. S. (2001). The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog. Neurobiol. 65, 391-426. doi:10.1016/S0301-0082(01)00011-9
79. Grumolato, L., Liu, G., Mong, P., Mudbhary, R., Biswas, R., Arroyave, R., et al. (2010). Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors. Genes Dev. 24, 2517-2530. doi:10.1101/gad.1957710
80. Guo, W., Murthy, A. C., Zhang, L., Johnson, E. B., Schaller, E. G., Allan, A. M., et al. (2012). Inhibition of GSK3beta improves hippocampus-dependent learning and rescues neurogenesis in a mouse model of fragile X syndrome. Hum. Mol. Genet. 21, 681-691. doi: 10.1093/hmg/ddr501
81. Hall, A. C., Lucas, F. R., and Salinas, P. C. (2000). Axonal remodeling and synaptic differentiation in the cerebellum is regulated by WNT-7a signaling. Cell 100, 525-535. doi: 10.1016/S0092-8674(00)80689-3
82. Han, C., and Lin, X. (2005). Shifted from Wnt to Hedgehog signaling pathways. Mol. Cell 17, 321-322. doi: 10.1016/j.molcel.2005.01.009
83. Harms, M. P., Wang, L., Mamah, D., Barch, D. M., Thompson, P. A., and Csernansky, J. G. (2007). Thalamic shape abnormalities in individuals with schizophrenia and their nonpsychotic siblings. J. Neurosci. 27, 13835-13842. doi: 10.1523/JNEUROSCI.2571-07.2007
84. Hayashi-Takagi, A., Takaki, M., Graziane, N., Seshadri, S., Murdoch, H., Dunlop, A. J., et al. (2010). Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1. Nat. Neurosci. 13, 327-332. doi: 10.1038/nn.2487
85. Henriquez, J. P., Webb, A., Bence, M., Bildsoe, H., Sahores, M., Hughes, S. M., et al. (2008). Wnt signaling promotes AChR aggregation at the neuromuscular synapse in collaboration with agrin. Proc. Natl. Acad. Sci. U.S.A. 105, 18812-18817. doi:10.1073/pnas.0806300105
86. Hermann, D., Both, M., Ebert, U., Gross, G., Schoemaker, H., Draguhn, A., et al. (2009). Synaptic transmission is impaired prior to plaque formation in amyloid precursor protein-overexpressing mice without altering behaviorallycorrelated sharp wave-ripple complexes. Neuroscience 162, 1081-1090. doi: 10.1016/j.neuroscience.2009.05.044
87. Hernandez, F., Borrell, J., Guaza, C., Avila, J., and Lucas, J. J. (2002). Spatial learning deficit in transgenic mice that conditionally over-express GSK-3beta in the brain but do not form tau filaments. J. Neurochem. 83, 1529-1533. doi: 10.1046/j.1471-4159.2002.01269.x
88. Hickey, M. A., Kosmalska, A., Enayati, J., Cohen, R., Zeitlin, S., Levine, M. S., et al. (2008). Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice. Neuroscience 157, 280-295. doi: 10.1016/j.neuroscience.2008.08.041
89. Hodar, C., Assar, R., Colombres, M., Aravena, A., Pavez, L., Gonzalez, M., et al. (2010). Genome-wide identification of new Wnt/beta-catenin target genes in the human genome using CART method. BMC Genomics 11:348. doi: 10.1186/1471-2164-11-348
90. Holtmaat, A., and Svoboda, K. (2009). Experience-dependent structural synaptic plasticity in the mammalian brain. Nat. Rev. Neurosci. 10, 647-658. doi:10.1038/nrn2699
91. Hooper, C., Killick, R., and Lovestone, S. (2008). The GSK3 hypothesis of Alzheimer's disease. J. Neurochem. 104, 1433-1439. doi: 10.1111/j.1471-4159.2007.05194.x
92. Hooper, C., Markevich, V., Plattner, F., Killick, R., Schofield, E., Engel, T., et al. (2007). Glycogen synthase kinase-3 inhibition is integral to long-term potentiation. Eur. J. Neurosci. 25, 81-86. doi: 10.1111/j.1460-9568.2006.05245.x
93. Hughes, J. R. (2009). Absence seizures: a review of recent reports with new concepts. Epilepsy Behav. 15, 404-412. doi: 10.1016/j.yebeh.2009.06.007
94. Inestrosa, N. C., and Arenas, E. (2010). Emerging roles of Wnts in the adult nervous system. Nat. Rev. Neurosci. 11, 77-86. doi: 10.1038/nrn2755
95. Inestrosa, N., De Ferrari, G. V., Garrido, J. L., Alvarez, A., Olivares, G. H., Barria, M. I., et al. (2002). Wnt signaling involvement in beta-amyloid-dependent neurodegeneration. Neurochem. Int. 41, 341-344. doi: 10.1016/S0197-0186(02)00056-6
96. Inestrosa, N. C., Montecinos-Oliva, C., and Fuenzalida, M. (2012). Wnt signaling: role in Alzheimer disease and schizophrenia. J. Neuroimmune Pharmacol. 7, 788-807. doi: 10.1007/s11481-012-9417-5
97. Jackson, B. M., and Eisenmann, D. M. (2012). Beta-catenin-dependent Wnt signaling in C. elegans: teaching an old dog a new trick. Cold Spring Harb. Perspect. Biol. 4, a007948. doi: 10.1101/cshperspect.a007948
98. Jang, M. H., Bonaguidi, M. A., Kitabatake, Y., Sun, J., Song, J., Kang, E., et al. (2013). Secreted frizzled-related protein 3 regulates activity-dependent adult hippocampal neurogenesis. Cell Stem Cell 12, 215-223. doi: 10.1016/j.stem.2012.11.021
99. Jing, L., Lefebvre, J. L., Gordon, L. R., and Granato, M. (2009). Wnt signals organize synaptic prepattern and axon guidance through the zebrafish unplugged/MuSK receptor. Neuron 61, 721-733. doi: 10.1016/j.neuron.2008.break12.025
100. Jope, R. S., and Johnson, G. V. (2004). The glamour and gloom of glycogen synthase kinase-3. Trends Biochem. Sci. 29, 95-102. doi: 10.1016/j.tibs.2003.12.004
101. Kaladchibachi, S. A., Doble, B., Anthopoulos, N., Woodgett, J. R., and Manoukian, A. S. (2007). Glycogen synthase kinase 3, circadian rhythms, and bipolar disorder: a molecular link in the therapeutic action of lithium. J. Circadian Rhythms 5, 3. doi: 10.1186/1740-3391-5-3
102. Kikuchi, A., Yamamoto, H., Sato, A., and Matsumoto, S. (2011). New insights into the mechanism of Wnt signaling pathway activation. Int. Rev. Cell Mol. Biol. 291, 21-71. doi: 10.1016/B978-0-12-386035-4.00002-1
103. Killick, R., Ribe, E. M., Al-Shawi, R., Malik, B., Hooper, C., Fernandes, C., et al. (2012). Clusterin regulates beta-amyloid toxicity via Dickkopf-1-driven induction of the wnt-PCP-JNK pathway. Mol. Psychiatry. doi: 10.1038/mp.2012.163 [Epub ahead of print].
104. Kim, W., Kim, M., and Jho, E. H. (2013). Wnt/beta-catenin signalling: from plasma membrane to nucleus. Biochem. J. 450, 9-21. doi: 10.1042/BJ20121284
105. Klein, P. S., and Melton, D. A. (1996). A molecular mechanism for the effect of lithium on development. Proc. Natl. Acad. Sci. U.S.A. 93, 8455-8459. doi: 10.1073/pnas.93.16.8455
106. Kleschevnikov, A. M., Belichenko, P. V., Villar, A. J., Epstein, C. J., Malenka, R. C., and Mobley, W. C. (2004). Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of down syndrome. J. Neurosci. 24, 8153-8160. doi: 10.1523/JNEUROSCI.1766-04.2004
107. Kohn, A. D., and Moon, R. T. (2005). Wnt and calcium signaling: beta-cateninindependent pathways. Cell Calcium 38, 439-446. doi: 10.1016/j.ceca.2005. 06.022
108. Komuro, H., and Rakic, P. (1998). Orchestration of neuronal migration by activity of ion channels, neurotransmitter receptors, and intracellular Ca2+ fluctuations. J. Neurobiol. 37, 110-130. doi: 10.1002/(SICI)1097-4695(199810)37:1<110::AID-NEU9>3.0.CO;2-C
109. Koshimizu, H., Fukui, Y., Takao, K., Ohira, K., Tanda, K., Nakanishi, K., et al. (2011). Adenomatous polyposis coli heterozygous knockout mice display hypoactivity and age-dependent working memory deficits. Front. Behav. Neurosci. 5:85. doi: 10.3389/fnbeh.2011.00085
110. Krishnan, V., and Nestler, E. J. (2008). The molecular neurobiology of depression. Nature 455, 894-902. doi: 10.1038/nature07455
111. Lambert, J. C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., et al. (2009). Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat. Genet. 41, 1094-1099. doi: 10.1038/ng.439
112. Larson, J., Wong, D., and Lynch, G. (1986). Patterned stimulation at the theta frequency is optimal for the induction of hippocampal long-term potentiation. Brain Res. 368, 347-350. doi: 10.1016/0006-8993(86)90579-2
113. Li, H. L., Wang, H. H., Liu, S. J., Deng, Y. Q., Zhang, Y. J., Tian, Q., et al. (2007). Phosphorylation of tau antagonizes apoptosis by stabilizing beta-catenin, a mechanism involved in Alzheimer's neurodegeneration. Proc. Natl. Acad. Sci. U.S.A. 104, 3591-3596. doi: 10.1073/pnas.0609303104
114. Lie, D. C., Colamarino, S. A., Song, H. J., Desire, L., Mira, H., Consiglio, A., et al. (2005). Wnt signalling regulates adult hippocampal neurogenesis. Nature 437, 1370-1375. doi: 10.1038/nature04108
115. Lips, E. S., Cornelisse, L. N., Toonen, R. F., Min, J. L., Hultman, C. M., Holmans, P. A., et al. (2012). Functional gene group analysis identifies synaptic gene groups as risk factor for schizophrenia. Mol. Psychiatry 17, 996-1006. doi: 10.1038/mp. 2011.117
116. Liu, X. B., Coble, J., van Luijtelaar, G., and Jones, E. G. (2007). Reticular nucleus-specific changes in alpha3 subunit protein at GABA synapses in genetically epilepsy-prone rats. Proc. Natl. Acad. Sci. U.S.A. 104, 12512-12517. doi: 10.1073/pnas.0705320104
117. Liu, C., Li, Y., Semenov, M., Han, C., Baeg, G. H., Tan, Y., et al. (2002). Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108, 837-847. doi: 10.1016/S0092-8674(02)00685-2
118. Logan, C. Y., and Nusse, R. (2004). The Wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 20, 781-810. doi: 10.1146/annurev.cellbio.20.010403.113126
119. Lu, B. (2003). BDNF and activity-dependent synaptic modulation. Learn. Mem. 10, 86-98. doi: 10.1101/lm.54603
120. Lu, W., Yamamoto, V., Ortega, B., and Baltimore, D. (2004). Mammalian Ryk is a Wnt coreceptor required for stimulation of neurite outgrowth. Cell 119, 97-108. doi: 10.1016/j.cell.2004.09.019
121. Lucas, F. R., and Salinas, P. C. (1997). WNT-7a induces axonal remodeling and increases synapsin I levels in cerebellar neurons. Dev. Biol. 192, 31-44. doi: 10.1006/dbio.1997.8734
122. Lucas, J. J., Hernandez, F., Gomez-Ramos, P., Moran, M. A., Hen, R., and Avila, J. (2001). Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. EMBO J. 20, 27-39. doi:10.1093/emboj/20.1.27
123. Lucki, I., Dalvi, A., and Mayorga, A. J. (2001). Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology 155, 315-322. doi: 10.1007/s002130100694
124. MacDonald, B. T., Tamai, K., and He, X. (2009). Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev. Cell 17, 9-26. doi: 10.1016/j.devcel.2009.06.016
125. Magby, J. P., Bi, C., Chen, Z. Y., Lee, F. S., and Plummer, M. R. (2006). Single-cell characterization of retrograde signaling by brain-derived neurotrophic factor. J. Neurosci. 26, 13531-13536. doi: 10.1523/JNEUROSCI.4576-06.2006
126. Maguschak, K. A., and Ressler, K. J. (2008). Beta-catenin is required for memory consolidation. Nat. Neurosci. 11, 1319-1326. doi: 10.1038/nn.2198
127. Maguschak, K. A., and Ressler, K. J. (2011). Wnt signaling in amygdaladependent learning and memory. J. Neurosci. 31, 13057-13067. doi: 10.1523/JNEUROSCI.3248-11.2011
128. Mao, B., Wu, W., Li, Y., Hoppe, D., Stannek, P., Glinka, A., et al. (2001). LDLreceptor-related protein 6 is a receptor for Dickkopf proteins. Nature 411, 321-325. doi: 10.1038/35077108
129. Marenco, S., Stein, J. L., Savostyanova, A. A., Sambataro, F., Tan, H. Y., Goldman, A. L., et al. (2012). Investigation of anatomical thalamo-cortical connectivity and FMRI activation in schizophrenia. Neuropsychopharmacology 37, 499-507. doi:10.1038/npp.2011.215
130. Marques, G. (2005). Morphogens and synaptogenesis in Drosophila. J. Neurobiol. 64, 417-434. doi: 10.1002/neu.20165
131. Masland, R. H. (1977). Maturation of function in the developing rabbit retina. J. Comp. Neurol. 175, 275-286. doi: 10.1002/cne.901750303
132. Mattson, M. P. (2004). Pathways towards and away from Alzheimer's disease. Nature 430, 631-639. doi: 10.1038/nature02621
133. Maya Vetencourt, J. F., Sale, A., Viegi, A., Baroncelli, L., De Pasquale, R., O'Leary, O. F., et al. (2008). The antidepressant fluoxetine restores plasticity in the adult visual cortex. Science 320, 385-388. doi: 10.1126/science.1150516
134. Mayeux, R., and Stern, Y. (2012). Epidemiology of Alzheimer disease. Cold Spring Harb. Perspect. Med. 2, pii: a006239. doi: 10.1038/nrneurol.2011.2. Epub 2011 Feb 8.
135. McMahon, A. P., and Moon, R. T. (1989a). Ectopic expression of the proto-oncogene int-1 in Xenopus embryos leads to duplication of the embryonic axis. Cell 58, 1075-1084. doi: 10.1016/0092-8674(89)90506-0
136. McMahon, A. P., and Moon, R. T. (1989b). Int-1 a proto-oncogene involved in cell signalling. Development 107(Suppl), 161-167.
137. Menendez, M. (2005). Down syndrome, Alzheimer's disease and seizures. Brain Dev. 27, 246-252. doi: 10.1016/j.braindev.2004.07.008
138. Mikels, A. J., and Nusse, R. (2006a). Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context. PLoS Biol. 4:e115. doi: 10.1371/journal.pbio.0040115
139. Mikels, A. J., and Nusse, R. (2006b). Wnts as ligands: processing, secretion and reception. Oncogene 25, 7461-7468. doi: 10.1038/sj.onc.1210053
140. Millar, J. K., Christie, S., and Porteous, D. J. (2003). Yeast two-hybrid screens implicate DISC1 in brain development and function. Biochem. Biophys. Res. Commun. 311, 1019-1025. doi: 10.1016/j.bbrc.2003.10.101
141. Minami, Y., Oishi, I., Endo, M., and Nishita, M. (2010). Ror-family receptor tyrosine kinases in noncanonical Wnt signaling: their implications in developmental morphogenesis and human diseases. Dev. Dyn. 239, 1-15. doi:10.1002/dvdy.21991.
142. Mire, E., Mezzera, C., Leyva-Diaz, E., Paternain, A. V., Squarzoni, P., Bluy, L., et al. (2012). Spontaneous activity regulates Robo1 transcription to mediate a switch in thalamocortical axon growth. Nat. Neurosci. 15, 1134-1143. doi: 10.1038/nn.3160
143. Miyaoka, T., Seno, H., and Ishino, H. (1999). Increased expression of Wnt-1 in schizophrenic brains. Schizophr. Res. 38, 1-6. doi: 10.1016/S0920-9964(98) 00179-0
144. Montcouquiol, M., Crenshaw, E. B. III., and Kelley, M. W. (2006). Noncanonical Wnt signaling and neural polarity. Annu. Rev. Neurosci. 29, 363-386. doi:10.1146/annurev.neuro.29.051605.112933
145. Moody, W. J., and Bosma, M. M. (2005). Ion channel development, spontaneous activity, and activity-dependent development in nerve and muscle cells. Physiol. Rev. 85, 883-941. doi: 10.1152/physrev.00017.2004
146. Moon, R. T., Kohn, A. D., De Ferrari, G. V., and Kaykas, A. (2004). WNT and beta-catenin signalling: diseases and therapies. Nat. Rev. Genet. 5, 691-701. doi:10.1038/nrg1427
147. Niehrs, C. (2010). On growth and form: a Cartesian coordinate system of Wnt and BMP signaling specifies bilaterian body axes. Development 137, 845-857. doi: 10.1242/dev.039651
148. Noble, W., Planel, E., Zehr, C., Olm, V., Meyerson, J., Suleman, F., et al. (2005). Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc. Natl. Acad. Sci. U.S.A. 102, 6990-6995. doi:10.1073/pnas.0500466102
149. Nusse, R., and Varmus, H. (2012). Three decades of Wnts: a personal perspective on how a scientific field developed. EMBO J. 31, 2670-2684. doi: 10.1038/emboj.2012.146
150. Oblak, A. L., Gibbs, T. T., and Blatt, G. J. (2010). Decreased GABA(B) receptors in the cingulate cortex and fusiform gyrus in autism. J. Neurochem. 114, 1414-1423. doi: 10.1111/j.1471-4159.2010.06858.x. Epub 2010 Jun 12.
151. Oblak, A. L., Gibbs, T. T., and Blatt, G. J. (2011). Reduced GABAA receptors and benzodiazepine binding sites in the posterior cingulate cortex and fusiform gyrus in autism. Brain Res. 1380, 218-228. doi: 10.1016/j.brainres.2010.09.021
152. Oishi, I., Suzuki, H., Onishi, N., Takada, R., Kani, S., Ohkawara, B., et al. (2003). The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signaling pathway. Genes Cells 8, 645-654. doi: 10.1046/j.1365-2443.2003.00662.x
153. Okamoto, H., Voleti, B., Banasr, M., Sarhan, M., Duric, V., Girgenti, M. J., et al. (2010). Wnt2 expression and signaling is increased by different classes of antidepressant treatments. Biol. Psychiatry 68, 521-527. doi:10.1016/j.biopsych.2010.04.023
154. Oliva, C. A., Vargas, J. Y., and Inestrosa, N. C. (2013). Wnt signaling: role in LTP, neural networks and memory. Ageing Res. Rev. 12, 786-800. doi:10.1016/j.arr.2013.03.006
155. Owens, D. F., and Kriegstein, A. R. (2002). Is there more to GABA than synaptic inhibition? Nat. Rev. Neurosci. 3, 715-727. doi: 10.1038/nrn919
156. Palop, J. J., Chin, J., Roberson, E. D., Wang, J., Thwin, M. T., Bien-Ly, N., et al. (2007). Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron 55, 697-711. doi: 10.1016/j.neuron.2007.07.025
157. Palop, J. J., and Mucke, L. (2009). Epilepsy and cognitive impairments in Alzheimer disease. Arch. Neurol. 66, 435-440. doi: 10.1001/archneurol.2009.15
158. Palop, J. J., and Mucke, L. (2010). Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nat. Neurosci. 13, 812-818. doi: 10.1038/nn.2583
159. Pei, J. J., Braak, E., Braak, H., Grundke-Iqbal, I., Iqbal, K., Winblad, B., et al. (1999). Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes. J. Neuropathol. Exp. Neurol. 58, 1010-1019. doi: 10.1097/00005072-199909000-00011
160. Penzes, P., Buonanno, A., Passafarro, M., Sala, C., and Sweet, R. A. (2013). Developmental vulnerability of synapses and circuits associated with neuropsychiatric disorders. J. Neurochem. 126, 165-182. doi: 10.1111/jnc. 12261
161. Penzes, P., Cahill, M. E., Jones, K. A., VanLeeuwen, J. E., and Woolfrey, K. M. (2011). Dendritic spine pathology in neuropsychiatric disorders. Nat. Neurosci. 14, 285-293. doi: 10.1038/nn.2741
162. Peradziryi, H., Tolwinski, N. S., and Borchers, A. (2012). The many roles of PTK7: a versatile regulator of cell-cell communication. Arch. Biochem. Biophys. 524, 71-76. doi: 10.1016/j.abb.2011.12.019
163. Phiel, C. J., Wilson, C. A., Lee, V. M., and Klein, P. S. (2003). GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. Nature 423, 435-439. doi: 10.1038/nature01640
164. Polakis, P. (2012). Wnt signaling in cancer. Cold Spring Harb. Perspect. Biol. 4, pii: a008052. doi: 10.1101/cshperspect.a008052
165. Prickaerts, J., Moechars, D., Cryns, K., Lenaerts, I., van Craenendonck, H., Goris, I., et al. (2006). Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania. J. Neurosci. 26, 9022-9029. doi:10.1523/JNEUROSCI.5216-05.2006
166. Purro, S. A., Dickins, E. M., and Salinas, P. C. (2012). The secreted Wnt antagonist Dickkopf-1 is required for amyloid beta-mediated synaptic loss. J. Neurosci. 32, 3492-3498. doi: 10.1523/JNEUROSCI.4562-11.2012
167. Quintanilla, R. A., Munoz, F. J., Metcalfe, M. J., Hitschfeld, M., Olivares, G., Godoy, J. A., et al. (2005). Trolox and 17beta-estradiol protect against amyloid beta-peptide neurotoxicity by a mechanism that involves modulation of the Wnt signaling pathway. J. Biol. Chem. 280, 11615-11625. doi: 10.1074/jbc.M411 936200
168. Rattner, A., Hsieh, J. C., Smallwood, P. M., Gilbert, D. J., Copeland, N. G., Jenkins, N. A., et al. (1997). A family of secreted proteins contains homology to the cysteinerich ligand-binding domain of frizzled receptors. Proc. Natl. Acad. Sci. U.S.A. 94, 2859-2863. doi: 10.1073/pnas.94.7.2859
169. Redmond, L., Kashani, A. H., and Ghosh, A. (2002). Calcium regulation of dendritic growth via CaM kinase IV and CREB-mediated transcription. Neuron 34, 999-1010. doi: 10.1016/S0896-6273(02)00737-7
170. Reya, T., and Clevers, H. (2005). Wnt signalling in stem cells and cancer. Nature 434, 843-850. doi: 10.1038/nature03319
171. Rockenstein, E., Torrance, M., Adame, A., Mante, M., Baron P, Rose JB., et al. (2007). Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation. J. Neurosci. 27, 1981-1991. doi: 10.1523/JNEUROSCI.4321-06.2007
172. Roheim, P. S., Carey, M., Forte, T., and Vega, G. L. (1979). Apolipoproteins in human cerebrospinal fluid. Proc. Natl. Acad. Sci. U.S.A. 76, 4646-4649. doi: 10.1073/pnas.76.9.4646
173. Rosso, S. B., Sussman, D., Wynshaw-Boris, A., and Salinas, P. C. (2005). Wnt signaling through dishevelled, Rac and JNK regulates dendritic development. Nat. Neurosci. 8, 34-42. doi: 10.1038/nn1374
174. Rulifson, E. J., Wu, C. H., and Nusse, R. (2000). Pathway specificity by the bifunctional receptor frizzled is determined by affinity for wingless. Mol. Cell 6, 117-126. doi:10.1016/S1097-2765(05)00018-3
175. Ryan, K. A., and Pimplikar, S. W. (2005). Activation of GSK-3 and phosphorylation of CRMP2 in transgenic mice expressing APP intracellular domain. J. Cell Biol. 171, 327-335. doi: 10.1083/jcb.200505078
176. Ryan, T. A., Reuter, H., Wendland, B., Schweizer, F. E., Tsien, R. W., and Smith, S. J. (1993). The kinetics of synaptic vesicle recycling measured at single presynaptic boutons. Neuron 11, 713-724. doi: 10.1016/0896-6273(93)90081-2
177. Ryder, J., Su, Y., Liu, F., Li, B., Zhou, Y., and Ni, B. (2003). Divergent roles of GSK3 and CDK5 in APP processing. Biochem. Biophys. Res. Commun. 312, 922-929. doi: 10.1016/j.bbrc.2003.11.014
178. Saganich, M. J., Schroeder, B. E., Galvan, V., Bredesen, D. E., Koo, E. H., and Heinemann, S. F. (2006). Deficits in synaptic transmission and learning in amyloid precursor protein (APP) transgenic mice require C-terminal cleavage of APP. J. Neurosci. 26, 13428-13436. doi: 10.1523/JNEUROSCI.4180-06.2006
179. Samuels, B. A., and Hen, R. (2011). Neurogenesis and affective disorders. Eur. J. Neurosci. 33, 1152-1159. doi: 10.1111/j.1460-9568.2011.07614.x
180. Schepeler, T., Mansilla, F., Christensen, L. L., Orntoft, T. F., and Andersen, C. L. (2007). Clusterin expression can be modulated by changes in TCF1-mediated Wnt signaling. J. Mol. Signal. 2, 6. doi: 10.1186/1750-2187-2-6
181. Schmidt, H. D., and Duman, R. S. (2007). The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav. Pharmacol. 18, 391-418. doi: 10.1097/FBP.0b013e3282ee2aa8
182. Schumacher, J., Laje, G., Abou Jamra, R., Becker, T., Muhleisen, T. W., Vasilescu, C., et al. (2009). The DISC locus and schizophrenia: evidence from an association study in a central European sample and from a meta-analysis across different European populations. Hum. Mol. Genet. 18, 2719-2727. doi:10.1093/hmg/ddp204
183. Schwarz-Romond, T., Fiedler, M., Shibata, N., Butler, P. J., Kikuchi, A., Higuchi, Y., et al. (2007). The DIX domain of dishevelled confers Wnt signaling by dynamic polymerization. Nat. Struct. Mol. Biol. 14, 484-492. doi: 10.1038/nsmb1247
184. Seib, D. R., Corsini, N. S., Ellwanger, K., Plaas, C., Mateos, A., Pitzer, C., et al. (2013). Loss of Dickkopf-1 restores neurogenesis in old age and counteracts cognitive decline. Cell Stem Cell 12, 204-214. doi: 10.1016/j.stem.2012.11.010
185. Seitz, R., Hackl, S., Seibuchner, T., Tamm, E. R., and Ohlmann, A. (2010). Norrin mediates neuroprotective effects on retinal ganglion cells via activation of the Wnt/beta-catenin signaling pathway and the induction of neuroprotective growth factors in Muller cells. J. Neurosci. 30, 5998-6010. doi:10.1523/JNEUROSCI.0730-10.2010
186. Selkoe, D. J. (2001). Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J. Alzheimers Dis. 3, 75-80.
187. Shimizu, H., Julius, M. A., Giarre, M., Zheng, Z., Brown, A. M., and Kitajewski, J. (1997). Transformation by Wnt family proteins correlates with regulation of beta-catenin. Cell Growth Differ. 8, 1349-1358.
188. Shimogori, T., VanSant, J., Paik, E., and Grove, E. A. (2004). Members of the Wnt, Fz, and Frp gene families expressed in postnatal mouse cerebral cortex. J. Comp. Neurol. 473, 496-510. doi: 10.1002/cne.20135
189. Simons, M., and Mlodzik, M. (2008). Planar cell polarity signaling: from fly development to human disease. Annu. Rev. Genet. 42, 517-540. doi: 10.1146/annurev.genet.42.110807.091432
190. Slusarski, D. C., Corces, V. G., and Moon, R. T. (1997a). Interaction of Wnt and a frizzled homologue triggers G-protein-linked phosphatidylinositol signalling. Nature 390, 410-413. doi: 10.1038/37138
191. Slusarski, D. C., Yang-Snyder, J., Busa, W. B., and Moon, R. T. (1997b). Modulation of embryonic intracellular Ca2+ signaling by Wnt-5A. Dev. Biol. 182, 114-120. doi: 10.1006/dbio.1996.8463
192. Smith, M. J., Wang, L., Cronenwett, W., Mamah, D., Barch, D. M., and Csernansky, J. G. (2011). Thalamic morphology in schizophrenia and schizoaffective disorder. J. Psychiatr. Res. 45, 378-385. doi: 10.1016/j.jpsychires.2010.08.003
193. Speese, S. D., and Budnik, V. (2007). Wnts: up-and-coming at the synapse. Trends Neurosci. 30, 268-275. doi: 10.1016/j.tins.2007.04.003
194. Sutton, L. P., Honardoust, D., Mouyal, J., Rajakumar, N., and Rushlow, W. J. (2007). Activation of the canonical Wnt pathway by the antipsychotics haloperidol and clozapine involves dishevelled-3. J. Neurochem. 102, 153-169. doi: 10.1111/j.1471-4159.2007.04527.x
195. Tabatadze, N., Tomas, C., McGonigal, R., Lin, B., Schook, A., and Routtenberg, A. (2012). Wnt transmembrane signaling and long-term spatial memory. Hippocampus 22, 1228-1241. doi: 10.1002/hipo.20991
196. Takashima, A., Murayama, M., Murayama, O., Kohno, T., Honda, T., Yasutake, K., et al. (1998). Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau. Proc. Natl. Acad. Sci. U.S.A. 95, 9637-9641. doi: 10.1073/pnas.95.16.9637
197. Takashima, A., Noguchi, K., Michel, G., Mercken, M., Hoshi, M., Ishiguro, K., et al. (1996). Exposure of rat hippocampal neurons to amyloid beta peptide (25-35) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3 beta. Neurosci. Lett. 203, 33-36. doi: 10.1016/0304-3940(95)12257-5
198. Takashima, A., Noguchi, K., Sato, K., Hoshino, T., and Imahori, K. (1993). Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity. Proc. Natl. Acad. Sci. U.S.A. 90, 7789-7793. doi: 10.1073/pnas.90. 16.7789
199. Tamai, K., Semenov, M., Kato, Y., Spokony, R., Liu, C., Katsuyama, Y., et al. (2000). LDL-receptor-related proteins in Wnt signal transduction. Nature 407, 530-535. doi: 10.1038/35035117
200. Tan, Y., Yu, D., Busto, G. U., Wilson, C., and Davis, R. L. (2013). Wnt signaling is required for long-term memory formation. Cell Rep. 4, 1082-1089. doi: 10.1016/j.celrep.2013.08.007
201. Tilleman, K., Stevens, I., Spittaels, K., Haute, C. V., Clerens, S., Van Den Bergh, G., et al. (2002). Differential expression of brain proteins in glycogen synthase kinase-3 transgenic mice: a proteomics point of view. Proteomics 2, 94-104. doi:10.1002/1615-9861(200201)2:1<94::AID-PROT94>3.0.CO;2-W
202. Toledo, E. M., Colombres, M., and Inestrosa, N. C. (2008). Wnt signaling in neuroprotection and stem cell differentiation. Prog. Neurobiol. 86, 281-296. doi: 10.1016/j.pneurobio.2008.08.001
203. Toledo, E. M., and Inestrosa, N. C. (2010). Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1DeltaE9 mouse model of Alzheimer's disease. Mol. Psychiatry 15, 272-285, 228. doi: 10.1038/mp.2009.72
204. Valvezan, A. J., and Klein, P. S. (2012). GSK-3 and Wnt signaling in neurogenesis and bipolar disorder. Front. Mol. Neurosci. 5:1. doi: 10.3389/fnmol.2012.00001
205. van Amerongen, R., Mikels, A., and Nusse, R. (2008). Alternative wnt signaling is initiated by distinct receptors. Sci. Signal. 1, re9. doi: 10.1126/scisignal.135re9
206. van Amerongen, R., and Nusse, R. (2009). Towards an integrated view of Wnt signaling in development. Development 136, 3205-3214. doi: 10.1242/dev.033910
207. Varela-Nallar, L., Alfaro, I. E., Serrano, F. G., Parodi, J., and Inestrosa, N. C. (2010). Wingless-type family member 5A (Wnt-5a) stimulates synaptic differentiation and function of glutamatergic synapses. Proc. Natl. Acad. Sci. U.S.A. 107, 21164-21169. doi: 10.1073/pnas.1010011107
208. Veeman, M. T., Axelrod, J. D., and Moon, R. T. (2003). A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling. Dev. Cell 5, 367-377. doi: 10.1016/S1534-5807(03)00266-1
209. Vogt, D. L., Thomas, D., Galvan, V., Bredesen, D. E., Lamb, B. T., and Pimplikar, S. W. (2011). Abnormal neuronal networks and seizure susceptibility in mice overexpressing the APP intracellular domain. Neurobiol. Aging 32, 1725-1729. doi: 10.1016/j.neurobiolaging.2009.09.002
210. Walsh, D. M., and Selkoe, D. J. (2004). Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 44, 181-193. doi: 10.1016/j.neuron.2004.09.010
211. Wang, J., Ruan, N. J., Qian, L., Lei, W. L., Chen, F., and Luo, Z. G. (2008). Wnt/beta-catenin signaling suppresses Rapsyn expression and inhibits acetylcholine receptor clustering at the neuromuscular junction. J. Biol. Chem. 283, 21668-21675. doi: 10.1074/jbc.M709939200
212. Wang, J., Shou, J., and Chen, X. (2000). Dickkopf-1, an inhibitor of the Wnt signaling pathway, is induced by p53. Oncogene 19, 1843-1848. doi: 10.1038/sj.onc.1203503
213. Wang, J., Sinha, T., and Wynshaw-Boris, A. (2012). Wnt signaling in mammalian development: lessons from mouse genetics. Cold Spring Harb. Perspect. Biol. 4, pii: a007963. doi: 10.1101/cshperspect.a007963
214. Wayman, G. A., Impey, S., Marks, D., Saneyoshi, T., Grant, W. F., Derkach, V., et al. (2006). Activity-dependent dendritic arborization mediated by CaM-kinase I activation and enhanced CREB-dependent transcription of Wnt-2. Neuron 50, 897-909. doi: 10.1016/j.neuron.2006.05.008
215. Wehrli, M., Dougan, S. T., Caldwell, K., O'Keefe, L., Schwartz, S., Vaizel-Ohayon, D., et al. (2000). arrow encodes an LDL-receptor-related protein essential for wingless signalling. Nature 407, 527-530. doi: 10.1038/35035110
216. Weisstaub, N. V., Zhou, M., Lira, A., Lambe, E., Gonzalez-Maeso, J., Hornung, J. P., et al. (2006). Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice. Science 313, 536-540. doi: 10.1126/science.1123432
217. Wexler, E. M., Geschwind, D. H., and Palmer, T. D. (2008). Lithium regulates adult hippocampal progenitor development through canonical Wnt pathway activation. Mol. Psychiatry 13, 285-292. doi: 10.1038/sj.mp.4002093
218. Wisniewska, M. B. (2013). Physiological role of beta-catenin/TCF signaling in neurons of the adult brain. Neurochem. Res. 38, 1144-1155. doi: 10.1007/s11064-013-0980-9
219. Wisniewska, M. B., Nagalski, A., Dabrowski, M., Misztal, K., and Kuznicki, J. (2012). Novel beta-catenin target genes identified in thalamic neurons encode modulators of neuronal excitability. BMC Genomics 13:635. doi: 10.1186/1471-2164-13-635
220. Wong, G. T., Gavin, B. J., and McMahon, A. P. (1994). Differential transformation of mammary epithelial cells by Wnt genes. Mol. Cell. Biol. 14, 6278-6286. doi: 10.1128/MCB.14.9.6278
221. Wray, J., and Hartmann, C. (2012). WNTing embryonic stem cells. Trends Cell Biol. 22, 159-168. doi: 10.1016/j.tcb.2011.11.004
222. Yamanaka, H., Moriguchi, T., Masuyama, N., Kusakabe, M., Hanafusa, H., Takada, R., et al. (2002). JNK functions in the non-canonical Wnt pathway to regulate convergent extension movements in vertebrates. EMBO Rep. 3, 69-75. doi:10.1093/embo-reports/kvf008
223. Yang, J., Si, T., Ling, Y., Ruan, Y., Han, Y., Wang, X., et al. (2003). Association study of the human FZD3 locus with schizophrenia. Biol. Psychiatry 54, 1298-1301. doi: 10.1016/S0006-3223(03)00291-9
224. Yi, H., Hu, J., Qian, J., and Hackam, A. S. (2012). Expression of brain-derived neurotrophic factor is regulated by the Wnt signaling pathway. Neuroreport 23, 189-194. doi: 10.1097/WNR.0b013e32834fab06
225. Yu, X., and Malenka, R. C. (2003). Beta-catenin is critical for dendritic morphogenesis. Nat. Neurosci. 6, 1169-1177. doi: 10.1038/nn1132
226. Yuste, R., Peinado, A., and Katz, L. C. (1992). Neuronal domains in developing neocortex. Science 257, 665-669. doi: 10.1126/science.1496379
227. Zhang, Y., McLaughlin, R., Goodyer, C., and LeBlanc, A. (2002). Selective cytotoxicity of intracellular amyloid beta peptide1-42 through p53 and Bax in cultured primary human neurons. J. Cell Biol. 156, 519-529. doi: 10.1083/jcb.2001 10119
228. Zhang, Z., Hartmann, H., Do, V. M., Abramowski, D., Sturchler-Pierrat, C., Staufenbiel, M., et al. (1998). Destabilization of beta-catenin by mutations in presenilin-1 potentiates neuronal apoptosis. Nature 395, 698-702. doi: 10.1038/27208